- Home
- BEATW vs TROW Comparison
BEATW vs TROW Comparison
Compare BEATW & TROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEATW
- TROW
- Stock Information
- Founded
- BEATW 2015
- TROW 1937
- Country
- BEATW United States
- TROW United States
- Employees
- BEATW 21
- TROW N/A
- Industry
- BEATW Retail: Computer Software & Peripheral Equipment
- TROW Investment Bankers/Brokers/Service
- Sector
- BEATW Technology
- TROW Finance
- Exchange
- BEATW Nasdaq
- TROW Nasdaq
- Market Cap
- BEATW N/A
- TROW N/A
- IPO Year
- BEATW N/A
- TROW N/A
- Fundamental
- Price
- BEATW $0.60
- TROW $88.44
- Analyst Decision
- BEATW
- TROW Sell
- Analyst Count
- BEATW 0
- TROW 12
- Target Price
- BEATW N/A
- TROW $97.67
- AVG Volume (30 Days)
- BEATW 4.7K
- TROW 2.7M
- Earning Date
- BEATW 03-14-2025
- TROW 05-02-2025
- Dividend Yield
- BEATW N/A
- TROW 5.74%
- EPS Growth
- BEATW N/A
- TROW 17.91
- EPS
- BEATW N/A
- TROW 9.15
- Revenue
- BEATW N/A
- TROW $7,093,600,000.00
- Revenue This Year
- BEATW N/A
- TROW $4.52
- Revenue Next Year
- BEATW N/A
- TROW $3.51
- P/E Ratio
- BEATW N/A
- TROW $9.67
- Revenue Growth
- BEATW N/A
- TROW 9.80
- 52 Week Low
- BEATW $0.50
- TROW $77.85
- 52 Week High
- BEATW $0.62
- TROW $125.81
- Technical
- Relative Strength Index (RSI)
- BEATW N/A
- TROW 47.58
- Support Level
- BEATW N/A
- TROW $82.86
- Resistance Level
- BEATW N/A
- TROW $90.65
- Average True Range (ATR)
- BEATW 0.00
- TROW 4.26
- MACD
- BEATW 0.00
- TROW 0.78
- Stochastic Oscillator
- BEATW 0.00
- TROW 82.28
About BEATW Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.